Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

NEW ON THE MARKET
Parkinson's disease: inhaled levodopa (INBRIJA) for off periods

THERAPY FROM A CRITICAL VIEWPOINT
Baricitinib (OLUMIANT) against COVID-19

a-t READERS QUESTIONS AND COMMENTS
Vascular calcification due to coumarin anticoagulants?

IN BRIEF
The new “flu” vaccines for 2022/23
Insufficient information on the antiemetic therapy during treatment with apomorphine (e.g. APO-GO)
Icosapent ethyl (VAZKEPA) off market
Is vitamin D effective against fractures in healthy adults?
EMA and FDA: identical data differently interpreted

SIDE EFFECTS
Myocarditis/pericarditis with the protein-based SARS-CoV-2 vaccine NVX-COV2373 (NUVAXOVID)
PML with the multiple sclerosis drug ocrelizumab (OCREVUS)  free article 
Biliary tract diseases - increases risk also with DPP-4 inhibitors
© 2024 arznei-telegramm